Tharimmune Investor Relations Material
Latest events
Q2 2025
14 Aug, 2025
Corporate Presentation
24 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tharimmune Inc
Access all reports
Tharimmune Inc. is a biopharmaceutical company focused on the development of immune-modulating therapies for inflammatory diseases and cancer. The company specializes in small molecule and biologic drug candidates designed to regulate immune responses and target disease pathways. Tharimmune conducts clinical research and drug development to address unmet medical needs in autoimmune disorders, oncology, and fibrosis-related conditions. The company is headquartered in Westlake Village, California, and its shares are listed on the NASDAQ.
Key slides for Tharimmune Inc
Corporate Presentation
Tharimmune Inc
Corporate Presentation
Tharimmune Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
THAR
Country
🇺🇸 United States